NEIMETH Stock Overview
Manufactures and markets pharmaceutical and animal health care products in Nigeria and Ghana.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Neimeth International Pharmaceuticals Plc Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₦1.96 |
| 52 Week High | ₦2.45 |
| 52 Week Low | ₦1.50 |
| Beta | 0.28 |
| 11 Month Change | 22.50% |
| 3 Month Change | -1.01% |
| 1 Year Change | 18.79% |
| 33 Year Change | 12.00% |
| 5 Year Change | 256.36% |
| Change since IPO | -4.25% |
Recent News & Updates
Recent updates
Shareholder Returns
| NEIMETH | NG Pharmaceuticals | NG Market | |
|---|---|---|---|
| 7D | 12.6% | 3.5% | -0.6% |
| 1Y | 18.8% | 17.0% | 70.7% |
Return vs Industry: NEIMETH exceeded the NG Pharmaceuticals industry which returned 17% over the past year.
Return vs Market: NEIMETH underperformed the NG Market which returned 70.7% over the past year.
Price Volatility
| NEIMETH volatility | |
|---|---|
| NEIMETH Average Weekly Movement | 7.1% |
| Pharmaceuticals Industry Average Movement | 4.0% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in NG Market | 9.7% |
| 10% least volatile stocks in NG Market | 2.8% |
Stable Share Price: NEIMETH has not had significant price volatility in the past 3 months.
Volatility Over Time: NEIMETH's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1957 | 202 | J. Valentine Okelu | www.neimethplc.com.ng |
Neimeth International Pharmaceuticals Plc manufactures and markets pharmaceutical and animal health care products in Nigeria and Ghana. The company operates through two segments, Pharmaceuticals and Animal Health. It also provides health care, ethical, and veterinary related products; and poultry and a range of anthelmintic products, as well as enhancing medicaments.
Neimeth International Pharmaceuticals Plc Fundamentals Summary
| NEIMETH fundamental statistics | |
|---|---|
| Market cap | ₦8.38b |
| Earnings (TTM) | -₦2.60b |
| Revenue (TTM) | ₦2.39b |
3.5x
P/S Ratio-3.2x
P/E RatioIs NEIMETH overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| NEIMETH income statement (TTM) | |
|---|---|
| Revenue | ₦2.39b |
| Cost of Revenue | ₦1.28b |
| Gross Profit | ₦1.11b |
| Other Expenses | ₦3.70b |
| Earnings | -₦2.60b |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.61 |
| Gross Margin | 46.33% |
| Net Profit Margin | -108.75% |
| Debt/Equity Ratio | 269.6% |
How did NEIMETH perform over the long term?
See historical performance and comparison